IM Cannabis (IMCC) Stock Price, Financials & Analysis

Key Stats

Market Cap473,387.25

P/E-0.06

FCF (Yr)3.37 Mn

ROA (Yr)-33.32

EV to EBIT0.39

Net Income (Yr)-8.41 Mn

Enterprise Value-4.23 Mn

Add ratio to table…

About

IM Cannabis Corp. is an international cannabis company focused on the importation, distribution and sale of medical cannabis products to medical patients in Israel and Germany. The company operates medical cannabis retail pharmacies, online platforms, distribution centers and logistical hubs in Israel through its subsidiaries. In Germany, it imports cannabis and sells through its own IMC branded products and exclusive ultra premium Canadian brands via its subsidiary…

Revenue is generated primarily from the sale of medical cannabis flower and extracts, with additional income from cannabis accessories and related non cannabis items. In the fiscal year ended December 31 2025, total revenue was 54,731 thousand Canadian dollars, of which medical cannabis products contributed 53,186 thousand and other products contributed 1,545 thousand. The company sells to medical patients, licensed pharmacies and healthcare providers in both Israel and Germany.

The company operates through the following segments: Medical Cannabis Products and Other Products.

Medical Cannabis Products: This segment involves the importation, distribution and sale of medical cannabis flower and extracts to patients in Israel and Germany, including branded product lines such as IMC, BLK MKT and various high THC strains.
Other Products: This segment comprises the sale of cannabis accessories and related non cannabis items, such as products offered through partnerships with companies like Vessel Brand Inc.

The medical cannabis industry is highly competitive with competition varying by jurisdiction. In Israel, the company faces established local producers and brands, while in Germany it competes with licensed manufacturers and distributors ranging from large multinationals to new market entrants. Competitive advantages include the well known IMC brand, a cross border supply chain, regulatory expertise and EU GMP certified facilities that support product quality and reliability.

The company serves medical patients through its retail pharmacies and online platforms in Israel and supplies licensed pharmacies in Germany. Specific partners include Vessel Brand Inc. for accessory distribution in Israel, GlassHouse Botanics Inc. as a cannabis supplier in Germany and Avant Brands Inc. for brand licensing in the German market. The customer base consists primarily of patients with qualifying medical conditions and the pharmacies that dispense prescribed medical cannabis.

How IM Cannabis ranks

Ranked against the 40 companies in Tobacco and Cannabis58 metrics · as of Nov 6, 2026

Valuation

12 metrics · Lower multiples rank higher; a negative multiple ranks last

P/ENegative earnings −0.06xMedian 19.9x 11^th
P/FCFNegative free cash flow −0.91xMedian 18.9x 8^th
P/Operating cash flowNegative operating cash flow −0.93xMedian 10.6x 9^th
P/S 0.01xMedian 0.97x 97^th
P/BNegative shareholder equity −0.12xMedian 1.09x Not meaningful —
P/Tangible bookNegative tangible equity −0.11xMedian 1.21x Not meaningful —
EV/EBITDANegative EBITDA −0.81xMedian 13.0x 7^th
EV/EBITNegative EBIT −0.71xMedian 18.3x 9^th
EV/Revenue 0.24xMedian 1.09x 88^th
EV/FCFNegative free cash flow −15.9xMedian 18.6x 39^th
EV/Operating cash flowNegative operating cash flow −16.2xMedian 13.2x 39^th
PEG (3Y EPS CAGR)Negative earnings 0.00Median 0.57 Not meaningful —

Growth

14 metrics · Year-on-year growth and three-year compound annual growth

Revenue growth (1Y) −11.9%Median 5.3% 21^st
Revenue CAGR (3Y) −6.6%Median −0.1% 25^th
Gross profit growth (1Y) −54.2%Median 3.7% 3^rd
Gross profit CAGR (3Y) −20.0%Median 3.9% 10^th
Operating income growth (1Y) −681%Median −11.0% 6^th
Operating income CAGR (3Y) 30.0%Median 27.0% 59^th
Net income growth (1Y) −699%Median 7.6% 6^th
Net income CAGR (3Y) 52.6%Median 16.2% 82^nd
EPS growth (1Y) −306%Median −7.9% 9^th
EPS CAGR (3Y) 66.8%Median 23.4% 85^th
Operating cash flow growth (1Y) −127%Median 6.9% 9^th
Operating cash flow CAGR (3Y) 64.8%Median 9.2% 88^th
Free cash flow growth (1Y) −129%Median 16.0% 9^th
Free cash flow CAGR (3Y) 65.3%Median 32.4% 91^st

Profitability

14 metrics · Margins, returns on capital and the quality of earnings

Gross margin 12.6%Median 43.3% 3^rd
EBITDA margin −29.3%Median 1.7% 11^th
Operating margin −33.0%Median −6.4% 15^th
Pretax margin −40.4%Median −12.1% 21^st
Net margin −23.5%Median −13.1% 29^th
FCF margin −1.5%Median 0.4% 42^nd
Operating cash flow margin −1.5%Median 4.3% 39^th
Return on equity —Median −29.9% No data —
Return on assets −78.4%Median −12.9% 14^th
Return on invested capital —Median −4.4% No data —
Return on capital employed —Median −3.0% No data —
Asset turnover 1.93xMedian 0.59x 94^th
Cash conversion (OCF / net income)Net income is not positive 0.04xMedian 1.19x Not meaningful —
Stock comp / revenue —Median 2.5% No data —

Financial Health

11 metrics · Leverage, liquidity and solvency; less debt ranks higher

Debt / assets 48.9%Median 22.5% 21^st
Debt / equityNegative shareholder equity −2.18xMedian 0.40x Not meaningful —
Net debt / EBITDAEBITDA is not positive −0.76xMedian 2.31x Not meaningful —
Debt / FCFFree cash flow is not positive −17.3xMedian 3.30x Not meaningful —
Liabilities / assets 122%Median 67.5% 13^th
Equity / assetsNegative shareholder equity −22.4%Median 32.5% 13^th
Interest coverage −2.02xMedian −2.02x 50^th
Current ratio 0.56xMedian 1.66x 11^th
Quick ratio 0.29xMedian 0.72x 16^th
Cash ratio 0.06xMedian 0.40x 8^th
Altman Z-score −16.5Median −1.19 19^th

S.No.	Ticker	Company	Market Cap	P/E	P/S	Total Debt (Qtr)
1	PM	Philip Morris International Inc.	302.04 Bn	28.20	7.00	47.56 Bn
2	BTI	British American Tobacco p.l.c.	131.52 Bn	-	-	46.47 Bn
3	MO	Altria Group, Inc.	126.46 Bn	15.58	5.38	24.06 Bn
4	CURLF	Curaleaf Holdings, Inc.	2.38 Bn	-232.99	1.77	0.63 Bn
5	TRLV	Trulieve Cannabis Corp.	2.12 Bn	-4.47	1.86	0.19 Bn
6	RLX	RLX Technology Inc.	1.95 Bn	32.92	2.79	0.02 Bn
7	GTBIF	Green Thumb Industries Inc.	1.43 Bn	14.49	1.15	0.55 Bn
8	IMCC	IM Cannabis Corp.	0.00 Bn	-0.06	0.01	0.01 Bn

S.No.

Ticker

Company

Market Cap

P/E

P/S

Total Debt (Qtr)

Philip Morris International Inc.

302.04 Bn

28.20

7.00

47.56 Bn

BTI

British American Tobacco p.l.c.

131.52 Bn

46.47 Bn

Altria Group, Inc.

126.46 Bn

15.58

5.38

24.06 Bn

CURLF

Curaleaf Holdings, Inc.

2.38 Bn

-232.99

1.77

0.63 Bn

TRLV

Trulieve Cannabis Corp.

2.12 Bn

-4.47

1.86

0.19 Bn

RLX

RLX Technology Inc.

1.95 Bn

32.92

2.79

0.02 Bn

GTBIF

Green Thumb Industries Inc.

1.43 Bn

14.49

1.15

0.55 Bn

IMCC

IM Cannabis Corp.

0.00 Bn

-0.06

0.01

0.01 Bn

IM Cannabis IMCC

About

Geographical areas [axis] Breakdown of Revenue (2025)

Products and services [axis] Breakdown of Revenue (2025)

How IM Cannabis ranks

Valuation

Growth

Profitability

Financial Health

Shareholder Returns

Peer Comparison

IM Cannabis IMCC

About

Geographical areas [axis] Breakdown of Revenue (2025)

Products and services [axis] Breakdown of Revenue (2025)

How IM Cannabis ranks

Valuation

Growth

Profitability

Financial Health

Shareholder Returns

Peer Comparison

Create an account

Sign In

Reset Password